John Vaughn, Anthony Masaquel, Carolina Reyes, Farah Hossain, Eric Zuk, Rebecca Straubing, Matthew Davis, Scott Huntington. "Treatment inequities in newly diagnosed diffuse large B-cell lymphoma (DLBCL): Comparing polatuzumab vedotin in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) vs rituximab in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) among Medicare beneficiaries." Blood, 2025. doi:10.1182/blood-2025-4489